相关实验视频

Updated: Sep 18, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

在社区获得的肺炎和COVID-19中的不同血小板蛋白释放概况

Osoul Chouchane¹, Valentine Léopold¹, Erik H A Michels¹

¹Center for Experimental and Molecular Medicine, Amsterdam University Medical Center - Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

ERJ open research

|June 24, 2025

概括

来自COVID-19患者的血小板释放的炎症蛋白比社区获得性肺炎 (CAP) 患者的更多. 在COVID-19中这种增强的血小板活性与更糟糕的临床结果有关,包括增加的死亡风险.

科学领域:

免疫学免疫学免疫学
血液学血液学血液学
传染性疾病传染性疾病

背景情况:

血小板在宿主防御感染方面至关重要,释放出促炎和促凝蛋白.
肺炎,特别是COVID-19,对全球健康造成了重大负担.
了解肺炎中的血小板功能对于管理严重感染至关重要.

研究的目的:

调查和比较社区获得性肺炎 (CAP) 和COVID-19的住院患者的血小板蛋白释放概况.
确定血小板激活标志物和蛋白质释放是否与这些患者群体的临床结果相关.

主要方法:

从CAP,COVID-19患者和用受体激动剂 (GPVI,PAR1) 或中等控制体化血小板.
使用免疫试验测量超级生物中的九种血小板特异性蛋白质.
对P-选择素和活性GPIIbIIIa表面表达对血小板激活的流细胞计评估.

主要成果:

与对照组相比,来自CAP患者的血小板显示,自发化学激素释放减少.
在COVID-19患者的血小板中,与对照组和CAP患者相比,化学因子,PAI-1和CD40连接体的释放增强.
在COVID-19患者中,GPVI诱导的P-选择素,CD40连接体,PAI-1和CCL5的释放升高与增加通风需求和死亡风险相关.

结论:

截然不同的血小板蛋白释放概况区分了CAP和COVID-19患者.
COVID-19与生物活性血小板产品的释放增加有关,这与不良的临床结果有关.
血小板激活标志物 (P-selectin,GPIIbIIIa) 在患者组之间没有显著差异.

更多相关视频

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

相关概念视频

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...